News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
129,797 Results
Type
Article (4671)
Company Profile (19)
Press Release (125107)
Multimedia
Podcasts (6)
Webinars (2)
Section
Business (36895)
Career Advice (113)
Deals (5841)
Drug Delivery (7)
Drug Development (7319)
Employer Resources (12)
FDA (3343)
Job Trends (2419)
News (54084)
Policy (4138)
Tag
Academia (406)
Accelerated approval (5)
ADA (2)
Adcomms (9)
Allergies (18)
Alliances (11550)
ALS (22)
Alzheimer's disease (510)
Antibody-drug conjugate (ADC) (47)
Approvals (3444)
Artificial intelligence (239)
ASCO (77)
Autoimmune disease (29)
Automation (27)
Bankruptcy (46)
Best Places to Work (2056)
BIO (12)
BIOSECURE Act (1)
Biosimilars (13)
Biotechnology (11)
Bladder cancer (36)
Brain cancer (15)
Breast cancer (230)
Cancer (1479)
Cardiovascular disease (72)
Career advice (104)
Career pathing (2)
CAR-T (35)
CDC (4)
Celiac Disease (1)
Cell therapy (80)
Cervical cancer (15)
Clinical research (6430)
Collaboration (506)
Compensation (45)
Complete response letters (5)
COVID-19 (517)
CRISPR (8)
C-suite (182)
Cystic fibrosis (18)
Data (1379)
Decentralized trials (1)
Depression (57)
Dermatology (5)
Diabetes (46)
Diagnostics (6531)
Digital health (25)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (50)
Drug pricing (4)
Drug shortages (3)
Duchenne muscular dystrophy (10)
Earnings (15801)
Editorial (1)
Employer branding (2)
Employer resources (12)
Events (22250)
Executive appointments (186)
FDA (4013)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (4)
Funding (302)
Gene editing (12)
Generative AI (12)
Gene therapy (41)
GLP-1 (66)
Government (670)
Guidances (98)
Healthcare (3453)
Hematology (25)
HIV (17)
Huntington's disease (1)
IgA nephropathy (10)
Immunology and inflammation (12)
Immuno-oncology (10)
Indications (29)
Infectious disease (586)
Inflammatory bowel disease (17)
Influenza (27)
Intellectual property (40)
Interviews (13)
IPO (2280)
IRA (2)
Job creations (432)
Job search strategy (98)
JPM (2)
Kidney cancer (11)
Labor market (3)
Layoffs (28)
Leadership (1)
Legal (564)
Liver cancer (16)
Longevity (9)
Lung cancer (196)
Lymphoma (111)
Machine learning (16)
Management (3)
Manufacturing (149)
Marketing (1)
MASH (25)
Medical device (2906)
Medtech (2954)
Mergers & acquisitions (3810)
Metabolic disorders (110)
mRNA (14)
Multiple sclerosis (59)
NASH (3)
Neurodegenerative disease (90)
Neuropsychiatric disorders (26)
Neuroscience (774)
NextGen: Class of 2026 (806)
Non-profit (624)
Now hiring (3)
Obesity (33)
Opinion (19)
Ovarian cancer (46)
Pain (19)
Pancreatic cancer (62)
Parkinson's disease (51)
Partnered (3)
Patents (82)
Patient recruitment (78)
Peanut (5)
People (9699)
Pharmaceutical (1)
Pharmacy benefit managers (2)
Phase 1 (1956)
Phase 2 (2781)
Phase 3 (2342)
Pipeline (1686)
Policy (11)
Postmarket research (242)
Preclinical (826)
Press Release (11)
Prostate cancer (119)
Psychedelics (34)
Radiopharmaceuticals (175)
Rare diseases (109)
Real estate (922)
Recruiting (5)
Regulatory (3739)
Reports (10)
Research institute (472)
Resumes & cover letters (15)
Rett syndrome (8)
RNA editing (1)
RSV (8)
Schizophrenia (13)
Series A (42)
Series B (31)
Service/supplier (1)
Sickle cell disease (5)
Special edition (1)
Spinal muscular atrophy (17)
Sponsored (10)
Startups (654)
Stomach cancer (2)
Supply chain (14)
Tariffs (1)
The Weekly (6)
Vaccines (67)
Venture capital (16)
Weight loss (10)
Women's health (33)
Date
Today (26)
Last 7 days (68)
Last 30 days (316)
Last 365 days (5003)
2026 (2851)
2025 (5284)
2024 (6691)
2023 (7868)
2022 (11762)
2021 (10999)
2020 (10293)
2019 (7124)
2018 (5565)
2017 (5949)
2016 (6034)
2015 (7004)
2014 (5281)
2013 (4530)
2012 (4929)
2011 (5095)
2010 (4463)
Location
Africa (143)
Alabama (9)
Alaska (1)
Arizona (83)
Arkansas (3)
Asia (5991)
Australia (1446)
California (2769)
Canada (543)
China (114)
Colorado (158)
Connecticut (110)
Delaware (92)
Europe (17070)
Florida (407)
Georgia (122)
Idaho (5)
Illinois (259)
India (26)
Indiana (106)
Iowa (9)
Japan (85)
Kansas (18)
Kentucky (13)
Louisiana (8)
Maine (22)
Maryland (231)
Massachusetts (1324)
Michigan (117)
Minnesota (116)
Mississippi (1)
Missouri (62)
Montana (7)
Nebraska (10)
Nevada (15)
New Hampshire (23)
New Jersey (475)
New Mexico (17)
New York (692)
North Carolina (335)
North Dakota (8)
Northern California (1413)
Ohio (68)
Oklahoma (6)
Oregon (12)
Pennsylvania (246)
Rhode Island (9)
South America (167)
South Carolina (10)
Southern California (1111)
Tennessee (86)
Texas (568)
United States (8969)
Utah (222)
Virginia (92)
Washington D.C. (9)
Washington State (210)
West Virginia (1)
Wisconsin (81)
Wyoming (2)
129,797 Results for "pts diagnostics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Protagenic Therapeutics’ Lead Candidate PT00114 Attenuated Chronic Stress Responses in a Well-Established Rodent Model
June 30, 2026
·
4 min read
Press Releases
Protagenic Therapeutics Appoints Industry Veteran Bill Nichols Jr. as President to Accelerate Advancement of First-in-Class TCAP Pathway Therapy PT00114
April 23, 2026
·
4 min read
Press Releases
Protagenic Therapeutics Completes Phytanix Separation, Strengthens Balance Sheet and Repositions the Company Around PT00114
March 17, 2026
·
5 min read
Press Releases
Phanes Therapeutics Announces Updated Phase 2 Clinical Trial Results of Spevatamig (PT886) in Combination with Chemotherapy in Frontline Treatment of Metastatic PDAC at the 2026 ASCO Annual Meeting
May 29, 2026
·
4 min read
Press Releases
Results from Phase 1 Multiple-Dose Study of PT00114
December 10, 2025
·
4 min read
Press Releases
Phanes Therapeutics to Present Updated Phase 2 Clinical Trial Results of Spevatamig (PT886) in Combination with Chemotherapy in Frontline Treatment of Metastatic PDAC at the 2026 ASCO Annual Meeting
April 23, 2026
·
2 min read
Press Releases
Tivic To Report 2025 Year-End Financial Results Via Conference Call and Webcast on March 25th at 1:30pm PT / 4:30pm ET
March 23, 2026
·
4 min read
Press Releases
Predicta Biosciences and CIMA LAB Diagnostics Announce Agreement to Advance Ultrasensitive Blood-Based Diagnostics for Multiple Myeloma and Other Hematological Malignancies
June 10, 2026
·
2 min read
Press Releases
Cleveland Diagnostics Appoints Rich Ramko to Board of Directors
June 9, 2026
·
2 min read
Press Releases
Canada Diagnostic Centres, a Novacap Portfolio Company, Announces Acquisition of Shift Imaging
July 6, 2026
·
3 min read
1 of 12,980
Next
